呼吸機能低下の英語

呼吸器機能の低下を生じる肺疾患例文帳に追加

an abnormal condition of the lungs marked by decreased respiratory function発音を聞く  - 日本語WordNet

酸素の欠乏に伴う疲労の蓄積、ストレス、脈拍や呼吸数の増加、集中力の低下、運動機能の低下、頭痛、耳鳴り、吐き気などの諸症状の解消又は低減、運動能力の向上や維持、心身のリフレッシュ等を図ることのできる酸素供給用の剤の提供。例文帳に追加

To obtain an oxygen-containing soft capsule for supplying oxygen, which solves or reduces symptoms such as accumulation of fatigue, stress, increase in pulse and respiration rate, reduction in concentration, reduction in motor function, headache, ringing in the ears, nausea, etc., caused by oxygen deficiency, improves and maintains athletic ability and refreshes mind and body. - 特許庁

また、ＥＰ_４アゴニストを用いれば、神経変性疾患に伴う種々の症状（例えば、振戦、固縮、無動、寡動、動作緩慢、姿勢反射障害、自律神経障害、突進現象、歩行障害、うつ、記憶障害、筋萎縮、筋力低下、上肢機能障害、構音障害、嚥下障害、呼吸障害、しびれおよび麻痺等）の改善にも有用である。例文帳に追加

The use of EP_4 agonist improves various symptoms accompanying to neurodegenerative diseases (for example, tremor, rigidity, akinesia, oligokinesia, bradykinesia, postural reflex disorder, autonomic disturbance, pulsion, gait disorder, depression, dysmnesia, muscular atrophy, muscular depression, upper limb dysfunction, articulatory disorder, dysphagia, respiratory obstruction, palsy and paralysis). - 特許庁

Ｎ−［６−メトキシ−５−（２−メトキシフェノキシ）−２−（２−ピリミジニル）−４−ピリミジニル］−２−フェニルエテンスルホンアミドまたはその製薬学的に許容される塩を有効成分として含有する慢性閉塞性肺疾患患者の気道炎症抑制剤、換気機能低下改善剤、低酸素血症治療剤及び／又は慢性呼吸不全への進行抑制剤。例文帳に追加

An airway inflammation inhibitor, a ventilation dysfunction ameliorating agent, a therapeutic agent of hypoxemia and/or a progression inhibitor of chronic respiratory insufficiency of patients suffering from chronic obstructive pulmonary diseases comprise the N-[6-methoxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]-2-phenylethenesulfonamide or its pharmaceutically acceptable salt as an active ingredient. - 特許庁

循環器疾患として、高血圧、うっ血性心不全、狭心症、発作性心房細動、心室性不整脈、睡眠時無呼吸症候群及び腎不全に有用な治療薬であり、特に、高血圧として、治療抵抗性高血圧、夜間高血圧、早朝高血圧、肺機能低下を伴う高血圧及び閉塞性肺疾患を伴う高血圧治療薬である。例文帳に追加

The therapeutic agent is effective in treating the circulatory diseases of hypertension, congestive heart failure, angina pectoris, paroxysmal atrial fibrillation, ventricular arrhythmia, sleep apnea syndrome and renal failure; and is the agent for treating, in particular, such hypertension as therapy resistant hypertension, nocturnal hypertension, early-morning hypertension, hypertension accompanied by decreases of lung function and hypertension accompanied by obstructive pulmonary diseases. - 特許庁